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ABSTRACT 
The neural mechanisms mediating one-trial and multi-trial behavioral 
sensitization during early ontogeny are poorly understood. The purpose of this 
thesis was to assess the importance of D2-like receptors for the induction of 
cocaine- and methamphetamine-induced one-trial and multi-trial behavioral 
sensitization during the middle and late preweanling period. In a series of four 
experiments, rats were injected with saline or the selective dopamine D2-like 
receptor antagonist raclopride 15 min prior to treatment with the indirect 
dopamine agonists cocaine or methamphetamine. Acute control groups 
received two injections of saline. The pretreatment regimens occurred on 
either PND 16 or PND 20 (one-trial behavioral sensitization) or PND 13-16 or 
PND 17-20 (multi-trial behavioral sensitization). On PND 17 or PND 21, rats 
were challenged with either cocaine or methamphetamine and sensitized 
responding was assessed. With only a single exception, both one-trial and 
multi-trial cocaine- and methamphetamine-induced sensitization was evident 
on PND 17 and PND 21. Importantly, the D2-like receptor antagonist 
raclopride did not prevent the induction of cocaine- or 
methamphetamine-induced one-trial behavioral sensitization. In regards to 
multi-trial behavioral sensitization, raclopride failed to inhibit cocaine-induced 
sensitized responding on PND 17 and PND 21. Interestingly, higher doses of 
raclopride (0.5 and 1 mg/kg) were able to prevent the induction of multi-trial 
methamphetamine-induced sensitization on PND 17. Therefore, D2-like 
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receptor antagonism differentially affected methamphetamine-induced 
behavioral sensitization depending on whether a one-trial or multi-trial 
paradigm was employed. When considered together, these results suggest 
that the neural mechanisms underlying the methamphetamine-induced 
behavioral sensitization of preweanling rats differs depending on the type of 
experimental paradigm (one- vs multi-trial) being used. Other potential 
explanations (i.e., nonspecific antagonist effects, impact of contextual 
conditioning, etc.) for this interesting effect are presented in the Discussion. 
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 CHAPTER ONE: 
HUMAN MODELS OF ADDICTION 
Psychostimulants have addictive properties that can induce complex 
effects on human behavior. Taking into account the increasing rate of 
psychostimulant use, psychostimulant addiction has become a profound 
public health concern (Sax & Strakowski, 2001). One of the most frequently 
used models to study the underlying mechanisms of drug addiction is 
behavioral sensitization. Behavioral sensitization is characterized by a 
progressive increase in behavioral responsiveness as a result of repeated 
exposures to a psychostimulant drug (Kalivas & Stewart, 1991; Robinson & 
Becker 1986; Sax & Strakowski, 2001; Strakowski & Sax, 1998). Figure 1 
compares the typical pattern of drug-taking in human addicts with a model of 
behavioral sensitization in animals. 
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Figure 1. Comparison between Human Psychostimulant-induced Psychosis 
and an Experimental Model of Behavioral Sensitization in Rats. The Addiction 
Phase can Progressively Lead to Sensitization in Psychostimulant-induced 
Psychosis. In Rats, Repeated Exposure to Psychostimulants can Lead to 
Heightened Motor Activity. Adapted from Pierce and Kalivas (1997). 
Although most behavioral sensitization studies are based on animal 
models, recent evidence in the clinical literature has shown a role for 
sensitization in human drug-seeking (Strakowski & Sax, 1998). For instance, 
Strakowski, Sax, Setters, and Keck (1996) reported that volunteers with no 
prior substance abuse history showed a progressive increase in energy, 
mood, speech, and eye-blink rates when repeatedly treated with 
amphetamine (0.25 mg/kg) twice daily over a span of four days. In another 
study, participants showed a progressive increase in eye-blink rates and 
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motor activity after receiving a single oral dose of amphetamine (0.25 mg/kg) 
for six days (Strakowski & Sax, 1998). These data indicate that behavioral 
sensitization occurs in humans and that the phenomenon may play a role in 
drug addiction. 
While numerous studies have examined the sensitizing effects of 
psychostimulants in animal and human models, less focus has been paid to 
the underlying neurobiological processes responsible for behavioral 
sensitization. Dopamine plays a key role in mediating the stimulatory 
properties of psychostimulants. Therefore, it is not surprising that dopamine 
receptor systems have been linked to the induction (i.e., development) and 
expression of psychostimulant-induced behavioral sensitization (Kuribara & 
Uchihashi, 1993; Vezina & Stewart, 1989). The induction of behavioral 
sensitization appears to be due to transient changes in neural functioning, 
while the expression of sensitization is associated with enduring changes in 
cellular function during withdrawal (Kalivas & Stewart, 1991). 
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 CHAPTER TWO: 
DOPAMINE PHARMACOLOGY 
Introduction 
Catecholamine neurotransmitters are notable for their core chemical 
structure referred to as the catehol (McTavish, Cowen, & Sharp, 1999). 
Dopamine is one of the predominant catecholamine neurotransmitters in the 
central nervous system (Ho & Loh, 1972). It is involved in a variety of 
functions, such as motor activity, cognition, and hormone secretion (Jaber, 
Robinson, Missale, & Caron, 1996). 
In 1910, George Barger and James Ewens were the first to synthesize 
dopamine. With the progression of research, dopamine was discovered to be 
a neurotransmitter in the late 1950s. This was achieved when 
spectrophoto-fluorometric techniques revealed significantly higher 
concentrations of dopamine in the caudate nucleus than norepinephrine 
(Carlsson, Lindqvist, Magnusson, & Waldeck, 1958). The dopaminergic 
system was further explored by Dahlstrom and Fuxe (1965), who discovered 
dopamine-containing pathways and their associated projections to various 
areas of the forebrain. 
Dopamine Projection Pathways 
Dopaminergic neurons mediate gross and fine motor movements, as 
well as reinforcement and planning (Ando, Johanson, Seiden, & Schuster, 
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1985). Areas of the brain that have particularly high dopamine concentrations 
include the substantia nigra pars compacta, hypothalamus, and ventral 
tegmental area (Geffen, Jessell, Cuello & Iversen, 1976; Palkovits, 
Brownstein, Saavedra, & Axelrod, 1974). These specific brain regions give 
origin to three major dopamine projection pathways. The nigrostriatal pathway, 
which modulates motor activity, begins at the substantia nigra and projects to 
the basal ganglia (Geffen et al., 1976; Huang, Zhou, Chase, Gusella, Aronin, 
& DiFiglia, 1992). Interestingly, degeneration of nigral neurons, which make up 
the nigrostriatal pathway, contributes to the progression of Parkinson’s 
disease (Damier, Hirsch, Agid, & Graybiel, 1999). The mesolimbic pathway 
originates in the ventral tegmental area and projects to the nucleus 
accumbens (i.e., ventral striatum). These brain areas mediate reward and play 
a key role in addictive behaviors (Chang & Kitai, 1985). Lastly, the 
mesocortical pathway originates in the ventral tegmental area and projects to 
the prefrontal cortex (Carr & Sesack, 2000; Lewis & O’Donell, 2000). This 
pathway contributes to higher-level cognitive functions and planning 
(Seamans, Floresco, & Phillips, 1998). 
Synthesis of Dopamine 
Synthesis of dopamine occurs in several biochemical steps (Nagatsu, 
Levitt, & Udenfriend, 1964). The process is initiated when tyrosine is catalyzed 
by tyrosine hydroxylase (TH) and produces dihydroxyphenylalanine (L-DOPA) 
(Nagatsu, Levitt, & Udenfriend, 1964; Smidt, Smits, & Burbach, 2003). 
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Dopamine is made when L-DOPA is further catalyzed by the enzyme aromatic 
amino acid decarboxylase (AADC) (Roth, 1979; Sourkes, 1979). The rate of 
dopamine synthesis is determined by the activity of tyrosine hyrdroxylase (i.e. 
the rate-limiting step). Production of dopamine occurs in the presynaptic 
terminals of dopaminergic neurons, after which the neurotransmitter is 
packaged into synaptic vesicles. Dopamine is then released via 
calcium-dependent exocytosis (Binder, Kinkead, Owens, & Nemeroff, 2001). 
Dopamine Receptors: D1-Like and D2-Like 
The classification of dopamine receptors is based on their interaction 
with G-coupled protein complexes. There are a total of five dopamine receptor 
subtypes that can be categorized into two populations of dopamine receptors, 
namely D1-like and D2-like receptors. Based on similarities in 
pharmacological actions and structure, the D1-like family is made up of D1 
and D5 receptors; whereas, the D2-like family consists of the D2, D3, and D4 
receptors (Jaber et al., 1996). 
In regards to pharmacological actions, D1-like receptors are coupled 
with Gs complexes. When activated, these Gs complexes stimulate the activity 
of adenylyl cyclase and increase the production of cyclic AMP. In contrast, 
D2-like receptors are coupled with Gi complexes and inhibit the activation of 
adenylyl cyclase (Kebabian, Beaulieu, & Itoh, 1984). The disparate actions of 
D1-like and D2-like receptors are described in pharmacological studies using 
agonists and antagonists. For example, Roberts-Lewis et al. (1986) provided 
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evidence that D1-like receptors are positively coupled with adenylyl cyclase 
activity by measuring dopamine release after SKF38393 or amphetamine 
treatment. The inhibitory relationship between adenylyl cyclase activity and 
D2-like receptors was discovered by applying vasoactive intestinal peptide in 
the anterior pituitary gland (Onali, Schwartz, & Costa, 1981). 
Dopamine Receptor Distribution in the Brain 
D1-Like Receptors 
The D1 receptor subtype is the most widespread and highly 
concentrated dopamine receptor in the brain (Boyson, McGonigle, & Molinoff, 
1986). A technique called in-situ hybridization is commonly used to examine 
gene expression in individual cells (Langdale, 1994). In regards to distribution 
of dopamine receptors in the brain, in-situ hybridization studies have shown 
that dopamine D1 receptors are primarily localized in the striatum, nucleus 
accumbens, and olfactory tuburcle, whereas cells expressing D1 receptor 
mRNA are located in the thalamus, hypothalamus, and limbic system 
(Fremeau, Duncan, Fornaretto, Dearry, Gingrich, Breese, & Caron, 1991). 
Other techniques, such as autoradiography, have also been used to localize 
dopamine receptor sites. For example, Boyson et al. (1986) examined the 
distribution of dopamine receptors by using the D1-like radioligand SCH 
23390. Results showed that D1 receptors were present throughout the 
forebrain, with the highest densities occurring in the substantia nigra, nucleus 
accumbens, olfactory tubercle, and striatum (Boyson et al., 1986). 
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 Although difficult to examine due to the lack of selective ligands, D5 
receptor mRNA is expressed in striatum, cerebral cortex, lateral thalamus, 
medial thalamus, and hippocampus (Choi, Machida, & Ronnekleiv, 1995; 
Meador-Woodruff, Mansour, Grandy, Damask, Civelli, & Watson, 1992). 
D2-Like Receptors 
D2 receptors are found in lower quantities than D1 receptors (Boyson et 
al., 1986). In-situ hybridization revealed that D2 receptor mRNA was found in 
the ventral tegmental area, nucleus accumbens, olfactory tubercle, and 
substantia nigra as well as in other dopamine projection fields 
(Meador-Woodruff, Mansour, Bunzow, Van Tol, Watson, & Civelli, 1989). 
Autoradiography studies also show that D2 receptors are found in high 
densities in the olfactory bulb and lateral septum (Charuchinda, Supavilai, 
Karobath, & Palacios, 1987). 
The D3 receptor is expressed preferentially in the mesolimbic system, 
but in lower quantities than D1 and D2 receptors (Richtand et al., 1995). While 
D3 mRNA is found in the olfactory tubercle and nucleus accumbens, 
especially high densities of D3 mRNA are expressed in the islands of Calleja 
(Diaz, Levesque, Lammers, Griffon, Martres, Schwartz, & Sokoloff, 1995). 
Distribution of the D4 receptor is unique, because D4 mRNA expression 
is minuscule in striatal areas; whereas, D1, D2, D3, and D5 receptor mRNA is 
abundant in the striatum. The D4 receptor subtype is mainly concentrated in 
the hippocampus, lateral septal nucleus, entorhinal cortex, and medial 
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preoptic area of the hypothalamus (Primus, Thurkauf, Xu, Yevich, McInerney, 
Shaw, Tallman, & Gallager, 1997). 
 10 
 CHAPTER THREE: 
ONTOGENY OF THE DOPAMINE SYSTEM 
Previous studies examining the dopamine system during postnatal 
development have focused on age-dependent changes in dopamine levels 
and the distribution of dopamine receptors across brain. Techniques such as 
in-situ hybridization, autoradiography, as well as receptor binding are 
commonly used to visualize and quantify ontogenetic changes in the 
dopamine system. 
As is true of adult rats, dopamine neurons in neonatal and preweanling 
rats are predominantly found in the substantia nigra, ventral tegmental area, 
and hypothalamus. These brain regions give rise to three main pathways (i.e. 
the nigrostriatal, mesolimbic, and mesocortical pathways) that are present at 
birth (Antonopoulos, Dori, Dinopoulos, Chiotelli, Parnavelas, 2002; Chang & 
Kitai, 1985; Geffen, Jessell, Cuello, & Iversen, 1976; Lewis & O’Donell, 2000; 
Olson & Seiger, 1972). Dopamine synthesis can be detected at birth, with 
dopamine levels increasing linearly until approximately puberty, when adult 
levels are reached (Olson & Seiger, 1972; Park, Kitahama, Geffard, & Maeda, 
2000). 
Postnatal Development: D1-Like and D2-Like Receptors 
During the first three postnatal weeks, profound changes in the profile 
of dopamine receptors take place. As mentioned previously, dopamine 
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receptors are classified based on their interaction with G-coupled protein 
complexes that either stimulate or inhibit adenylyl cyclase activity. 
Autoradiography studies examining the development of dopamine receptors 
indicate that D1-like receptors steadily increase in density from postnatal day 
1 (PND 1) to around PND 28, when dopamine receptors have reached adult 
levels (Murrin & Zeng, 1990; Rao, Molinoff, & Joyce, 1991; Zeng, Hyttel, & 
Murrin, 1988). Other studies demonstrate a gradual increase in D1-like 
receptors until approximately the onset of puberty (PND 40) when dopamine 
receptors are over-expressed. The number of dopamine receptors then 
decline (pruning), to levels that are maintained throughout adulthood 
(Andersen, Thompson, Rutstein, Hostetter, & Teicher, 2000; Giorgi, DeMontis, 
Porceddu, Mele, Calderini, Toffano, & Biggio, 1987). 
D2-like receptors also progressively increase with age, and reach adult 
levels around PND 21 (Hartley & Seeman 1983; Murrin & Zeng, 1986; 
Schrambra, Duncan, Breese, Fornaretto, Caron, & Fremeau, 1994). Other 
studies report a linear increase in D2-like receptors up to adolescence when 
dopamine receptors are over-expressed, followed by a decline in receptors 
that are maintained throughout adulthood (Andersen et al., 2000). 
Dopamine Receptor Distribution During Postnatal Development 
D1-Like Receptors 
The D1 receptor subtype can be detected in the striatum and nucleus 
accumbens at birth (Leslie, Robertson, Cutler, & Bennett, 1991; Zeng, Hyttel, 
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& Murrin, 1988). In addition, D1 receptors are highly concentrated in the frontal 
cortex as well as the entorhinal cortex during early postnatal development 
(Tarazi & Baldessarini, 2000). Normal development of dopamine D1 receptors 
can be disrupted when neonatal pups are injected with the neurotoxin 
6-hydroxydopamine, resulting in a decrease in D1 binding sites (Neal & Joyce, 
1992). 
Postnatal development of the D5 receptor can be detected in the 
striatum, globus pallidus, frontal cortex, and cingulate cortex (Araki, Sims, & 
Bhide, 2007). The developmental profile of D5 mRNA expression shows a 
linear increase from PND 0 until PND 21, when they reach maximal levels 
(Araki et al., 2007). 
D2-Like Receptors 
 During early stages of development, the D2 receptor subtype is 
generally found in higher quantities than the D1 receptor (Tarazi & 
Baldessarini, 2000). More specifically, autoradiographic results show that D2 
receptor densities in the striatum and nucleus accumbens are greater than 
other dopamine receptor subtypes (Tarazi & Baldessarini, 2000). 
The ontogenetic profile of the D3 receptor is characterized by an 
increase in the number of binding sites across early postnatal development. 
For example, Gurevich, Himes, and Joyce (1998) showed that D3 mRNA 
expression and D3 binding sites were detectable in low quantities at PND 7 in 
both the nucleus accumbens and islands of Caleja. In these brain regions, D3 
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receptors reached maximal levels at PND 14 and PND 90, respectively. As 
with adults, the D3 receptor subtype show that they are preferentially localized 
in the islands of Calleja (Diaz et al., 1995; Levesque, Diaz, Pilon, Martres, 
Giros, Souil, Schott, Morgat, Schwartz, & Sokoloff, 1992). 
During early postnatal development, the D4 receptor subtype is present 
in lower quantities than D1 and D2 receptors in the nucleus accumbens, 
striatum, frontal cortex, and entorhinal cortex (Tarazi & Baldessarini, 2000). 
Interestingly, D4 mRNA expression reaches maximal levels by PND 3. This 
contrasts with the D2 receptor subtype, which does not reach maximal levels 
until PND 28 or later (Andersen et al., 2000; Nair & Mishra, 1995). 
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 CHAPTER FOUR: 
MECHANISM OF ACTION: INDIRECT DOPAMINE AGONISTS 
Indirect dopamine agonists, such as cocaine and amphetamine, 
increase extracellular monoamine concentrations. More specifically, cocaine 
preferentially increases dopamine, norepinephrine, and serotonin levels, 
whereas amphetamine increases dopamine and norepinephrine (Ritz, Lamb, 
Goldberg, & Kuhar, 1987; Seiden, Sabol, & Ricaurte, 1993). In terms of 
cocaine, monoamine concentrations are enhanced by blocking the reuptake of 
newly released neurotransmitter from the synaptic cleft (Meyer & Quenzer, 
2005). For example, using an in-vivo microdialysis technique, Reith, Li, and 
Yan (1997) discovered that dialysate levels of all three amines were increased 
in the ventral tegmental area following administration of cocaine (20 mg/kg). 
Excitatory amino acids, such as glutamate, also play a role in the behavioral 
effects of cocaine. Cocaine indirectly enhances glutamatergic 
neurotransmission by activating these excitatory neurons, particularly in the 
nucleus accumbens and ventral tegmental area (Kalivas & Duffy, 1998; Smith, 
Mo, Guo, Kunko, & Robinson, 1995). 
Amphetamine- and methamphetamine-like stimulants increase 
monoamine concentrations by blocking reuptake transporters; however, unlike 
cocaine, they also bind to monoamine transporters by acting as a false 
substrate. The end result is that amphetamine and methamphetamine 
promote reverse transport of cytosolic transmitter, thereby releasing 
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monoamines from non-vesicular stores (Reith, Li, & Yan, 1997). Fumagalli, 
Gainetdinov, Valenzano, and Caron (1998) reported an 18-fold increase in 
extracellular dopamine levels in wild type mice that were subcutaneously 
injected with methamphetamine (30 mg/kg). In the same study, DOPAC levels 
were decreased by roughly 60% in both wild type and DAT knockout mice. 
The latter finding shows that methamphetamine also increases dopamine 
levels by inhibiting monoamine oxidase (MAO), which is an enzyme that 
catabolizes dopamine (Fumagalli et al., 1998). 
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 CHAPTER FIVE: 
ADULT SENSITIZATION: INDIRECT DOPAMINE AGONISTS 
Indirect Dopamine Agonists: Adult Multi-Trial Sensitization 
Behavioral sensitization occurs when an animal is repeatedly exposed 
to various indirect dopamine agonists (e.g. cocaine, amphetamine, or 
methamphetamine), and is then challenged with the same drug at a later time 
point. This procedure results in an augmented locomotor response that can be 
observed when the animal is tested one day to several months after 
discontinuation of the drug (Kalivas & Stewart, 1991; Leith & Kuczenski, 1982; 
McDougall et al., 2007; Robinson & Becker, 1986). Using this paradigm, adult 
rats usually exhibit an enhanced locomotor response when challenged later 
with an indirect dopamine agonist (Leith & Kuczenski, 1982). 
Indirect dopamine agonists are able to produce short- and long-term 
behavioral sensitization in adult rats. For example, sensitization occurs when 
a short withdrawal interval is employed. In one case, rats receiving repeated 
treatments of methamphetamine, followed by a five-day withdrawal period, 
showed an enhanced behavioral response after a challenge injection of 
methamphetamine (Laviola, Pascucci, & Pieretti, 2001). Sensitization is also 
robust when a longer duration withdrawal period is used. Kolta, Shreve, De 
Souza, and Uretsky (1985) showed enhanced locomotor activity after rats 
were chronically treated with amphetamine and challenged 15 or 30 days 
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later. This enhanced locomotion occurs in parallel with increased levels of 
endogenous dopamine, which is evident after longer withdrawal periods. 
Drug dose is a contributing factor to the sensitizing effects of 
psychostimulants. More specifically, repetitive treatment with large doses of a 
psychostimulant typically produces strong behavioral sensitization (Frantz, 
O’Dell, & Parsons, 2007; Post & Rose, 1976). For example, repetitive 
injections of a low dose of cocaine (10 mg/kg) across a five-day interval 
produces increased locomotion with minute stereotypic movements (Frantz et 
al., 2007). Davidson and colleagues (2002), however, observed a more robust 
sensitized response, as well as intense stereotypy, when rats were repeatedly 
given 40 mg/kg cocaine across a six-day interval (Davidson, Lazarus, Lee, & 
Ellinwood, 2002). 
Repeated administration of various doses of amphetamine can also 
lead to sensitization. For instance, a low pretreatment dose of either 0.5 or 
1 mg/kg amphetamine is enough to produce sensitization (Hall, Stanis, Avila, 
& Gulley, 2008; Hooks, Jones, Neil, & Justice Jr., 1992). Higher doses of 
amphetamine lead to focused stereotypy, such as sniffing and licking (Eichler, 
Antelman, & Black, 1980). In regards to locomotion, Leith and Kuczenski 
(1982) observed a multi-phasic response after repeated administration of 
moderate to high doses of amphetamine (2 or 3 mg/kg) for six days. This 
multi-phasic response is best represented by a U-shape curve, in which there 
is a rapid onset of locomotor activity, a decrease in locomotion due to intense 
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focused stereotypy, followed by a post increase in locomotor activity (Leith & 
Kuczenski, 1982). 
Repeated administration of methamphetamine also causes a 
progressive increase in locomotor activity. For example, mice treated with 
10 doses of 1, 2, or 4 mg/kg methamphetamine showed a progressive 
enhancement in locomotor activity. In general, mice receiving 1 mg/kg 
methamphetamine showed a slight increase in locomotor sensitization; 
whereas, 4 mg/kg methamphetamine produced robust stereotypic behavior 
(Hirabayashi & Alam, 1981). 
During the conditioning phase, the nature of the drug-environment 
pairings can affect the magnitude of the sensitized response. More 
specifically, behavioral sensitization is more pronounced when the adult rat or 
mouse is pretreated and tested in the same environment (i.e. 
context-dependent sensitization) (Anagnostaras & Robinson, 1996; Battisti, 
Chang, Uretsky, & Wallace, 1999; Drew & Glick, 1989; McDougall et al., 
2007). In contrast, behavioral sensitization is weaker in adult animals when 
drug pretreatment and drug challenge occur in separate environments (i.e. 
context-independent sensitization). (Laviola, Wood, Kuhn, Francis & Spear, 
1995; McDougall, Cortez, Palmer, Herbert, Martinez, Charntikov, & Amodeo, 
2009). For example, adult rats failed to express a sensitized response when 
drug challenge occurred in a context that was never paired with the 
pretreatment drug (Anagnostaras, Schallert, & Robinson, 2002). 
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Indirect Dopamine Agonists: Adult One-Trial Sensitization 
Although most studies examine behavioral sensitization using multi-trial 
procedures, sensitization has also been observed in adult rats and mice after 
a single pretreatment injection of a psychostimulant (McDougall, Reichel, Cyr, 
Karper, Nazarian, & Crawford, 2005; Weiss, Post, Pert, Woodward, & 
Murman, 1989). When a one trial procedure is used, sensitization is typically 
measured soon after the pretreatment injection and within the same 
environmental context (i.e., pretreatment and test injections occur in the test 
chamber). For example, adult rats conditioned with 30 mg/kg cocaine showed 
robust locomotor sensitization when challenged a day later with 10 mg/kg 
cocaine (McDougall et al., 2007). Amphetamine-induced sensitization was 
also observed in wild type and D1-defiecient mice after a one-day 
pre-exposure phase (McDougall et al., 2005). 
Environmental context is especially critical when adult rats and mice 
are provided only a single exposure to a psychostimulant. For example, adult 
mice displayed robust behavioral sensitization when conditioned with a high 
dose of cocaine (40 mg/kg) and challenged one day later with a lower dose of 
cocaine (10 mg/kg) in the same previously novel environment (Jackson & 
Nutt, 1993). In contrast, adult rats and mice do not exhibit behavioral 
sensitization when pretreatment and testing occur in different environments. 
For example, adult male and female rats pretreated with cocaine in the home 
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cage showed a lack of sensitized responding when injected with cocaine in 
the testing chamber 24 hours later (McDougall et al., 2009). 
The ability of psychostimulants to enhance locomotion and stereotopy 
are dose-dependent. Increased locomotor activity is observed when the 
animal is pretreated with a high dose of psychostimulant and is then 
challenged with a lower dose (Battisti et al., 1999; Jackson et al., 1993; 
McDougall et al., 2007; 2009). Stereotypy is preferentially observed when high 
doses of psychostimulant are used. For example, Battisti and colleagues 
showed that mice pretreated with 10 mg/kg amphetamine and challenged 
48 hours later with 7 mg/kg amphetamine displayed robust stereotypic 
behaviors (Battisti et al., 2009). 
 21 
 CHAPTER SIX: 
PREWEANLING SENSITIZATION: INDIRECT DOPAMINE AGONISTS 
Indirect Dopamine Agonists in Preweanling Rats: 
Multi-Trial Behavioral Sensitization 
As is true with adult animals, young rats exhibit behavioral sensitization 
when repeatedly exposed to psychostimulants (e.g. cocaine, amphetamine, or 
methamphetamine) (Duke, O’Neil, & McDougall, 1997; McDougall, Duke, 
Bolanos, & Crawford, 1994; Wood, Tirelli, Syder, Heyser, LaRocca, & Spear, 
1998). Although qualitatively similar, behavioral sensitization differs between 
young and adult animals. Some of the factors that differentially affect 
behavioral sensitization in young and adult rats include duration of the 
withdrawal period, the number of drug exposures, as well as the importance of 
drug-environment pairings. 
Indirect dopamine agonists produce long-term behavioral sensitization 
in adult rats that can be detected for months after the last drug exposure 
(Leith & Kuczenski, 1982; Robinson et al., 1982). In contrast, the longevity of 
multi-trial behavioral sensitization in preweanling rats is much shorter. For 
example, McDougall and colleagues (1994) examined the effects of 
amphetamine-induced behavioral sensitization in the early preweanling period 
and found that amphetamine produced short-term sensitization when using a 
2-day interval, but long-term sensitization was not evident when an 8-day 
treatment-to-test interval was employed (McDougall et al., 1994). In another 
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case, however, long-term cocaine sensitization was evident during the late 
preweanling period when testing occurred after 21 days of drug abstinence 
(Snyder, Katovic, & Spear, 1998). Taken together, age-related neural changes 
appear to affect the magnitude of the sensitized response after short or long 
drug abstinence (Snyder et al., 1998). 
In adult rats, the dose of psychostimulant used is a constraining 
influence on the robustness of the sensitized response (Jackson & Nutt, 1993; 
Weiss, Post, Pert, Woodward, & Muran, 1989). Similarly, drug dose impacts 
pharmacological responsiveness during early ontogeny. For example, 
cocaine-induced behavioral sensitization was more robust when medium 
(15 mg/kg) to large doses (30 mg/kg) of cocaine were administered at 
PND 21, with an adult-like pattern of locomotor activity being evident (Ujike, 
Tsuchida, Akiyama, Fujiwara, & Kuroda, 1995). In addition, repeated 
treatment with a moderate dose (2 mg/kg) of methamphetamine produces 
robust behavioral sensitization in late preweanling age groups (Fujiwara, 
Kazahaya, Nakashima, Sato, & Otsuki, 1987). 
Environmental cues influence the sensitized responding of preweanling 
rats when a multi-trial procedure is used. Specifically, the sensitized response 
is more robust when pretreatment and testing occur in the same environment 
(i.e. context-dependent sensitization); however, the sensitized response is 
weaker or absent when pretreatment and testing occur in distinct 
environments (i.e. context-independent sensitization). For example, 
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preweanling rats repeatedly treated with cocaine (5, 15, or 30 mg/kg) in a 
novel context showed strong behavioral sensitization when tested in the same 
previously novel environment (Wood et al., 1998). In contrast, preweanling 
rats would only exhibit short-term behavioral sensitization, but not long-term 
sensitization, when cocaine was repeatedly administered in the home cage 
during the pretreatment phase (McDougall, Cortez, Palmer, Herbert, Martinez, 
Charntikov, & Amodeo, 2009; Zavala, Nazarian, Crawford, & McDougall, 
2000). 
Indirect Dopamine Agonists in Preweanling Rats: 
One-Trial Behavioral Sensitization 
Like adults, preweanling rats exhibit a strong sensitized response after 
being given a single exposure to a variety of indirect agonists (e.g. cocaine, 
methamphetamine, and amphetamine) (Herbert, Der-Ghazarian, Palmer, & 
McDougall, 2010; Kozanian, Gutierrez, Mohd-Yusof, & McDougall, 2012). 
Adult rats only show one-trial behavioral sensitization when a 
context-dependent procedure is used (Battisti, Uretsky, & Wallace, 2000; 
McDougall, Baella, Stuebner, Halladay, & Crawford, 2007); whereas, young 
rats show strong sensitized responding when pretreatment and testing occur 
in distinct environments. For example, preweanling rats pretreated with 
30 mg/kg cocaine showed robust context-independent sensitization when 
challenged with 20 mg/kg cocaine on the test day (McDougall, Kozanian, 
Greenfield, Horn, Gutierrez, & Mohd-Yusof, 2011). In another case, Kozanian 
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et al. (2012) showed that young rats conditioned with 4 mg/kg 
methamphetamine in the home cage exhibited strong context-independent 
behavioral sensitization when challenged 24 hours later with 2 mg/kg 
methamphetamine in the test chamber. 
Previous research has also characterized the ontogenetic profile of 
psychostimulant-induced one-trial behavioral sensitization. More specifically, 
psychostimulants preferentially induce one-trial behavioral sensitization 
depending on the age of the animal. For example, McDougall et al. (2011) 
showed that cocaine produced robust one-trial behavioral sensitization when 
young rats were pretreated on PND 19 and tested on PND 21, while various 
dose combinations of methamphetamine and amphetamine did not produce 
one-trial behavioral sensitization in this age group. In contrast, one-trial 
cocaine-induced behavioral sensitization was not evident when younger 
(PND 16-17) and older (PND 24-25) rats were tested. Methamphetamine, on 
the other hand, was able to produce one-trial sensitization in younger age 
groups (PND 12-13 or PND 16-17) (Kozanian et al., 2012). These 
age-dependent differences in psychostimulant-induced effects could be due to 
ontogenetic changes in the dopamine system (see “Ontogeny of the 
Dopamine System” chapter). 
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 CHAPTER SEVEN: 
NEURAL MECHANISMS UNDERLYING THE DEVELOPMENT 
AND EXPRESSION OF BEHAVIORAL SENSITIZATION 
Previous studies have employed selective D1-like and D2-like receptor 
antagonists to assess the neural mechanisms responsible for the induction 
(i.e. development) and expression of behavioral sensitization. Current theory 
suggests that the induction of behavioral sensitization is due to transient 
changes in neural function caused by repeated injections of the drug, while 
expression of the sensitized response is associated with enduring changes in 
cellular function during withdrawal (Kalivas & Stewart, 1991). D1-like and 
D2-like receptors are thought to play an important role in these processes, 
however, the relationship of these receptors to sensitization is complex. 
Induction of Behavioral Sensitization 
Role of Dopamine D1-Like Receptors 
Researchers have suggested that stimulation of D1-like receptors, 
particularly in the ventral tegmental area, is necessary for the induction of 
amphetamine-induced behavioral sensitization (Vezina, 1996). Curiously, the 
importance of D1-like receptors appears to vary depending on the 
psychostimulant used. Specifically, D1-like receptor antagonists block the 
induction of amphetamine-induced behavioral sensitization (Vezina & Stewart 
1989). For example, rats repeatedly treated with SCH 23390 prior to 
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methamphetamine administration for 14 days did not show locomotor 
sensitization when tested after 3 months of drug abstinence (Hamamura, 
Akiyama, Akimoto, Kashihara, Okumura, Ujike, & Otsuki, 1991). Likewise, 
Ujike, Onoue, Akiyama, Hamamura, and Otsuki (1989) showed that rats 
receiving daily administrations of SCH 23390 (0.5 mg/kg) in combination with 
methamphetamine (4 mg/kg) for 14 days did not show elevated locomotor or 
stereotypic behavior on the test day, thus indicating that SCH 23390 blocked 
the induction of methamphetamine-induced sensitization. 
In contrast, many studies have shown that SCH 23390 does not affect 
the induction of cocaine-induced behavioral sensitization when using a 
multi-trial paradigm (Kuribara & Uchihashi, 1993; Vezina & Stewart, 1989; 
White, Joshi, Koeltzow, & Hu, 1998). However, Fontana and colleagues 
(1993) reported that SCH 23390 was able to prevent the conditioned effects 
of one-trial cocaine-induced sensitization. Thus, it appears that D1-like 
receptor blockade differentially affects behavioral sensitization depending on 
the psychosimulant being used. It is possible that cocaine and amphetamine 
differentially affect compensatory mechanisms or redundant pathways 
(Karper, De La Rosa, Newman, Krall, Nazarian, McDougall, & Crawford, 2002; 
White et al., 1998). The discrepant findings reported by Fontana et al. (1993) 
suggest that D1-like receptors are associated with conditioning effects rather 
than reward; whether this factor may underlie the differences between cocaine 
and amphetamine is uncertain. 
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Role of Dopamine D2-Like Receptors 
D2-like receptors also play a role in mediating behavioral sensitization. 
For example, mice repeatedly treated with the D2-like antagonist haloperidol 
(0.025, 0.1, 0.4 mg/kg), followed by methamphetamine, showed a 
dose-dependent decrease in the strength of the sensitized response 
(Kuribara, 1994). In the same manner, other studies found that haloperidol 
was able to block the induction of cocaine-induced behavioral sensitization 
(Mattingly, Rowlett, Ellison, & Rase, 1996; Weiss et al., 1989). Interestingly, 
the D2-like receptor antagonist sulpiride was unable to block the induction of 
cocaine sensitization (Mattingly, Hart, Lim, & Perkins, 1994). The disparate 
actions of haloperidol and sulpiride could be due to their respective 
mechanisms of action. For example, haloperidol not only binds to dopamine 
receptor sites but, at high doses, binds to serotonin receptor sites (O’Dell, La 
Hoste, Wildmark, Shapiro, Potkin, & Marshall, 1990). Hence, the ability of 
haloperidol to block cocaine-induced sensitization may be related to its 
combined actions on dopaminergic and non-dopaminergic systems (Mattingly 
et al., 1995). Sulpiride also has great difficulty in crossing the blood-brain 
barrier, so sulpiride’s lack of efficacy could be due to pharmacokinetic factors. 
Although it is generally accepted that D2-like receptors are important 
for the induction of behavioral sensitization, the brain areas where these 
receptors are located is largely unknown. In 2002, Beyer and Steketee 
reported that D2-like receptors in the medial prefrontal cortex are responsible 
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for mediating the induction of behavioral sensitization; whereas, Jung and 
colleagues (2013) showed that stimulation of D2-like receptors in the nucleus 
accumbens is not involved the inductive process. 
In summary, the role of D1-like and D2-like receptors in mediating the 
induction of psychostimulant-induced behavioral sensitization is complex. For 
example, while D1-like receptors play a prominent role in the induction of 
amphetamine-induced sensitization, their importance for cocaine-induced 
sensitization is much less critical. Likewise, D2-like receptor functioning 
appears to be necessary for the induction of methamphetamine- and 
cocaine-induced multi-trial sensitization, although studies involving sulpiride 
provide inconsistent findings. Considering these disparate results, more 
research is needed to determine the importance of dopamine receptors for the 
induction of psychostimulant-induced behavioral sensitization. 
Expression of Behavioral Sensitization 
Role of D1-Like Receptors 
Stimulation of D1-like receptors in the nucleus accumbens is required 
for the expression of behavioral sensitization (Pierce & Kalivas, 1997). For 
example, rats and mice treated with SCH 23390 on the test day displayed an 
absence of cocaine or methamphetamine sensitization (Kuribara & Uchihashi, 
1994; White et al., 1981). In another case, administering SCH 23390 prior to 
cocaine at various intervals (Day 1, 17, 14, and 21) blocked the expression of 
cocaine-induced behavioral sensitization (McCreary & Marsden, 1993). 
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Role of D2-Like Receptors 
While dopamine D2-like receptors are involved in the induction of 
behavioral sensitization, these receptors are not necessary for the expression 
of sensitization. For example, the D2-like antagonist pimozide is unable to 
block the expression of amphetamine-induced sensitization (Beninger & 
Hahn, 1983). Similarly, Beninger and Herz (1986) found that pimozide 
(0.4 mg/kg) pretreatment failed to prevent the expression of cocaine-induced 
behavioral sensitization in a context-specific environment. 
In summary, repeated treatment with a psychostimulant can lead to 
neurochemical alterations that are associated with the long-term expression of 
behavioral sensitization. Although D1-like and D2-like receptors are intimately 
involved in the induction of amphetamine-induced sensitization, only D1-like 
receptors are necessary for expression. 
Development of Sensitization in Young Rats 
While numerous studies have focused on the role of dopamine 
receptors for the induction and expression of behavioral sensitization in adult 
rats and mice (Hamamura et al., 1991; Kuribara, 1994; Kuribara & Uchihashi, 
1994; Vezina & Stewart, 1989), the role of dopamine receptors for the 
ontogeny of behavioral sensitization has not been studied in detail. Recently, 
however, one study did examine the importance of D1-like receptors for the 
induction of psychostimulant-induced behavioral sensitization in preweanling 
rats. Using a one-trial procedure, rat pups were pretreated with SCH 23390 at 
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0, 15, 30, or 60 min before methamphetamine (2 mg/kg) or cocaine 
(20 mg/kg) administration. At none of these time points did D1-like receptor 
blockade disrupt sensitized responding. Thus, the inability of SCH 23390 to 
impact methamphetamine- or cocaine-induced behavioral sensitization 
suggests that D1-like receptor stimulation is unnecessary for behavioral 
sensitization during the preweanling period (Mohd-Yusof, Gonzalez, Veliz, & 
McDougall, 2014). 
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 CHAPTER EIGHT: 
SUMMARY 
Thesis Statement 
Behavioral sensitization occurs when rats are repeatedly exposed to 
various indirect dopamine agonists (e.g. cocaine, methamphetamine, or 
amphetamine). In multi-trial behavioral sensitization paradigms, adult rats and 
mice typically show robust “context-dependent” sensitization when drug 
pretreatment and testing occur in the same novel environment. 
“Context-independent” behavioral sensitization can also be observed in adults 
when pretreatment and testing occurs in two separate and distinct 
environments. Different patterns of results are observed in adult rats and mice 
when using a one-trial procedure; adults only exhibit one-trial behavioral 
sensitization if drug pretreatment and testing occur in the same previously 
novel environment. 
Preweanling rats also exhibit behavioral sensitization after repeated 
exposures to an indirect dopamine agonist; however, the sensitized 
responding appears to be weaker and less persistent than in adult rats (Kolta 
et al., 1990; Smith & Morell, 2008). Similar to adults, the multi-trial sensitized 
responding of preweanling rats is more robust when pretreatment and testing 
occur in the same environmental context (Zavala et al., 2000). Unlike adults 
however, preweanling rats exhibit robust context-independent behavioral 
sensitization when using a one-trial paradigm (Kozanian et al., 2012). When 
 32 
these results are considered together, it appears that the characteristics of 
behavioral sensitization (e.g. the strength and longevity of the sensitized 
response, the role of associative processes, etc.) differ dramatically across 
ontogeny. 
In adult rats, the neural mechanisms underlying behavioral sensitization 
differ depending on the psychostimulant being used. Previous studies have 
shown that the selective D1-like receptor antagonist SCH 23390 blocks the 
induction of amphetamine- and methamphetamine-, but not cocaine-induced 
sensitization (Hamamura et al., 1991; Ujike et al., 1989). The only exception 
was reported by Fontana et al. (1993), who demonstrated that SCH 23390 
prevented the conditioned effects of cocaine-induced sensitization when using 
a one-trial procedure. In terms of D2-like receptors, haloperidol blocks the 
induction of methamphetamine- and cocaine-induced behavioral sensitization 
in adult rats, while sulpiride is ineffective. Considering the inconsistent 
findings, more research is needed to assess the importance of dopamine 
receptors for the induction of behavioral sensitization. 
In contrast to the large number of studies examining the induction of 
psychostimulant-induced behavioral sensitization in adult rats and mice, the 
role dopamine receptors play in the ontogeny of behavioral sensitization has 
been largely ignored. In the only study to examine the importance of D1-like 
receptors during early ontogeny, Mohd-Yusof et al. (2014) showed that SCH 
23390 was unable to block methamphetamine- and cocaine-induced 
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behavioral sensitization of young rats. These results indicate that the 
mechanism mediating behavioral sensitization differ across ontogeny. 
The purpose of this thesis was to assess the importance of D2-like 
receptors for the induction of psychostimulant-induced behavioral sensitization 
during early ontogeny. Rats were assessed during both the middle 
(PND 13-17) and late (PND 17-21) preweanling periods because rats of these 
ages often show different patterns of psychostimulant-induced behavioral 
sensitization (Kozanian et al., 2012; McDougall et al., 2013). Likewise, both 
methamphetamine and cocaine were tested, since adult rat sensitization 
studies indicate that these two psychostimulants are differentially affected by 
D2-like receptor blockade (Mattingly et al., 1994; Weiss et al., 1989). 
The specific goals of this thesis were two-fold. First, to investigate the 
importance of the D2-like receptor for cocaine- and 
methamphetamine-induced one-trial behavioral sensitization during early 
ontogeny. It was predicted that the D2-like antagonist raclopride would 
prevent the induction of methamphetamine- and cocaine-induced behavioral 
sensitization at PND 17 and PND 21. The basis for this prediction is that 
raclopride prevents the induction of one-trial cocaine-induced sensitization in 
adult rats (Fontana et al., 1993). The second goal of this thesis was to assess 
the importance of the D2-like receptor for cocaine- and 
methamphetamine-induced multi-trial behavioral sensitization during the 
middle and late preweanling periods. It was predicted that raclopride would 
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block both methamphetamine- and cocaine-induced multi-trial behavioral 
sensitization at PND 17 and PND 21. Again, the basis for these predictions 
are adult rat studies showing that raclopride and pimozide attenuate 
sensitized responding when using multi-trial procedures (Beninger & Hahn, 
1983; Beninger & Herz, 1986; Ushijima, Carino, & Horita, 1995). 
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 CHAPTER NINE: 
MATERIALS AND METHODS 
Subjects were young male and female rats of Sprague-Dawley descent 
(Charles River, Hollister, CA) that were born and raised at California State 
University, San Bernardino (CSUSB). Litters were culled to ten pups on 
PND 3. All rats were housed on racks in large polycarbonate maternity cages 
(56 × 34 × 22 cm) with wire lids and Tek-Fresh® bedding (Harlan, 
Indianapolis, IN). Food and water was freely available. The colony room was 
maintained at 22-23˚C, and kept under a 12L:12D cycle, with behavioral 
testing occurring during the light phase of the cycle. Except during testing, rats 
were kept with the dam and littermates. Testing was done in a separate 
experimental room, maintained at 24-25˚C. Subjects were cared for according 
to the “Guide for the Care and Use of Laboratory Animals” (National Research 
Council, 2010) under a research protocol approved by the Institutional Animal 
Care and Use Committee of CSUSB. 
Apparatus 
Behavioral testing was performed in commercially available (Coulbourn 
Instruments, Allentown, PA, USA) activity monitoring chambers 
(25 × 25 × 41 cm) housed in a testing room separate from the animal colony. 
The activity chambers had acrylic walls, a gray plastic floor, and an open top. 
Each chamber included an X-Y photobeam array, with 16 photocells and 
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detectors, that was used to measure horizontal locomotor activity (distance 
traveled). Photobeam resolution is 0.76 cm. The position of each rat was 
determined every 100 ms (i.e., the sampling interval). 
Drugs 
(+)-Methamphetamine hydrochloride, ()-cocaine hydrochloride, and 
S(-)-raclopride (+)-tartrate were dissolved in saline. Drugs were purchased 
from Sigma-Aldrich (St. Louis, MO) and injected intraperitoneally (IP) at a 
volume of 5 ml/kg. 
Procedure 
Experiment 1: Effects of D2 Receptor Blockade on 
Cocaine-Induced One-Trial Behavioral Sensitization 
One-trial cocaine-induced behavioral sensitization was assessed on 
PND 20–21. On the pretreatment day, PND 20 rats were injected with 
raclopride (0, 0.1, 0.5, 1, or 5 mg/kg) followed, 15 min later, by an injection of 
30 mg/kg cocaine (see Figure 2). Rats in the acute control group were given 
two injections of saline. After the second injection, rats were placed in activity 
chambers and distance traveled was measured for 30 min. On the test day, all 
rats were injected with 20 mg/kg cocaine and placed in activity chambers for 
120 min. 
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 PND 20 PND 21 
Group Pretreatment Drugs Test Day Drug 
Control Group Saline Saline Cocaine (20 mg/kg) 
Sensitization Group Saline Cocaine (30 mg/kg) Cocaine (20 mg/kg) 
Antagonist Group 0.1 mg/kg Raclopride Cocaine (30 mg/kg) Cocaine (20 mg/kg) 
Antagonist Group 0.5 mg/kg Raclopride Cocaine (30 mg/kg) Cocaine (20 mg/kg) 
Antagonist Group 1 mg/kg Raclopride Cocaine (30 mg/kg) Cocaine (20 mg/kg) 
Antagonist Group 5 mg/kg Raclopride Cocaine (30 mg/kg) Cocaine (20 mg/kg) 
Figure 2. Schematic Showing Drug Treatments for the Various Groups in 
Experiment 1 
Experiment 2: Effects of D2 Receptor Blockade on 
Methamphetamine-Induced One-Trial Behavioral Sensitization 
Since indirect dopamine agonists preferentially induce one-trial 
sensitization at different ages (Kozanian et al., 2012), one-trial 
methamphetamine-induced sensitization was assessed on PND 16-17. On the 
pretreatment day, PND 16 rats were injected with raclopride (0, 0.1, 0.5, 1, or 
5 mg/kg) followed, 15 min later, by an injection of 4 mg/kg methamphetamine 
(see Figure 3). The acute control group was given two injections of saline. 
After the second injection, locomotor activity was assessed for 30 min. On the 
test day, all rats were injected with 2 mg/kg methamphetamine and locomotor 
activity was assessed for 120 min. Doses of cocaine and methamphetamine 
were based on previous studies using preweanling rats (Herbert et al., 2010; 
McDougall et al., 2007, 2011; Kozanian et al., 2012). 
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 PND 16 PND 17 
Group Pretreatment Drugs Test Day Drug 
Control Group Saline Saline METH (2 mg/kg) 
Sensitization Group Saline METH (4 mg/kg) METH (2 mg/kg) 
Antagonist Group 0.1 mg/kg Raclopride METH (4 mg/kg) METH (2 mg/kg) 
Antagonist Group 0.5 mg/kg Raclopride METH (4 mg/kg) METH (2 mg/kg) 
Antagonist Group 1 mg/kg Raclopride METH (4 mg/kg) METH (2 mg/kg) 
Antagonist Group 5 mg/kg Raclopride METH (4 mg/kg) METH (2 mg/kg) 
Figure 3. Schematic Showing Drug Treatments for the Various Groups in 
Experiment 2 
Experiment 3a: Effects of D2 Receptor Blockade on Cocaine- 
Induced Multi-Trial Behavioral Sensitization During the Late 
Preweanling Period 
On PND 17-20, rats were injected with raclopride (0, 0.5, or 1 mg/kg) 
followed, 15 min later, by an injection of 30 mg/kg cocaine (see Figure 4). 
Rats in the acute control group were given two injections of saline. After the 
second injection, rats were placed in activity chambers and distance traveled 
was measured for 30 min. On PND 21, all rats were injected with 20 mg/kg 
cocaine and placed in activity chambers for 120 min. 
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 PND 17-20 PND 21 
Group Pretreatment Drugs Test Day Drug 
Control Group Saline Saline Cocaine (20 mg/kg) 
Sensitization Group Saline Cocaine (30 mg/kg) Cocaine (20 mg/kg) 
Antagonist Group 0.1 mg/kg Raclopride Cocaine (30 mg/kg) Cocaine (20 mg/kg) 
Antagonist Group 0.5 mg/kg Raclopride Cocaine (30 mg/kg) Cocaine (20 mg/kg) 
Antagonist Group 1 mg/kg Raclopride Cocaine (30 mg/kg) Cocaine (20 mg/kg) 
Figure 4. Schematic Showing Drug Treatments for the Various Groups in 
Experiment 3a 
Experiment 3b: Effects of D2 Receptor Blockade on 
Methamphetamine-Induced Multi-Trial Behavioral Sensitization 
During the Late Preweanling Period 
To examine the effects of D2 receptor antagonism on 
methamphetamine, separate groups of rats were treated as in Experiment 3a, 
except that rats were pretreated with 4 mg/kg methamphetamine and tested 
with 2 mg/kg methamphetamine (see Figure 5). 
 
 PND 17-20 PND 21 
Group Pretreatment Drugs Test Day Drug 
Control Group Saline Saline METH (2 mg/kg) 
Sensitization Group Saline METH (4 mg/kg) METH (2 mg/kg) 
Antagonist Group 0.1 mg/kg Raclopride METH (4 mg/kg) METH (2 mg/kg) 
Antagonist Group 0.5 mg/kg Raclopride METH (4 mg/kg) METH (2 mg/kg) 
Antagonist Group 1 mg/kg Raclopride METH (4 mg/kg) METH (2 mg/kg) 
Figure 5. Schematic Showing Drug Treatments for the Various Groups in 
Experiment 3b 
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Experiment 4a: Effects of D2 Receptor Blockade on Cocaine- 
Induced Multi-Trial Behavioral Sensitization During the Middle 
Preweanling Period 
On PND 13-16, rats were injected with raclopride (0,0.5, or 1 mg/kg) 
followed, 15 min later, by an injection of 30 mg/kg cocaine (see Figure 6). 
Rats in the acute control group were given two injections of saline. After the 
second injection, rats were placed in activity chambers and distance traveled 
was measured for 30 min. On PND 17, all rats were injected with 20 mg/kg 
cocaine and placed in activity chambers for 120 min. 
 
 PND 13-16 PND 17 
Group Pretreatment Drugs Test Day Drug 
Control Group Saline Saline Cocaine (20 mg/kg) 
Sensitization Group Saline Cocaine (30 mg/kg) Cocaine (20 mg/kg) 
Antagonist Group 0.1 mg/kg Raclopride Cocaine (30 mg/kg) Cocaine (20 mg/kg) 
Antagonist Group 0.5 mg/kg Raclopride Cocaine (30 mg/kg) Cocaine (20 mg/kg) 
Antagonist Group 1 mg/kg Raclopride Cocaine (30 mg/kg) Cocaine (20 mg/kg) 
Figure 6. Schematic Showing Drug Treatments for the Various Groups in 
Experiment 4a 
Experiment 4b: Effects of D2 Receptor Blockade on 
Methamphetamine-Induced Multi-Trial Behavioral Sensitization 
During the Middle Preweanling Period 
To examine the effects of D2-like receptor antagonism on 
methamphetamine during the middle preweanling period, separate groups of 
rats were treated as in Experiment 4a, except that rats were pretreated with 
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4 mg/kg methamphetamine and tested with 2 mg/kg methamphetamine (see 
Figure 7). 
 
 PND 13-16 PND 17 
Group Pretreatment Drugs Test Day Drug 
Control Group Saline Saline METH (2 mg/kg) 
Sensitization Group Saline METH (4 mg/kg) METH (2 mg/kg) 
Antagonist Group 0.1 mg/kg Raclopride METH (4 mg/kg) METH (2 mg/kg) 
Antagonist Group 0.5 mg/kg Raclopride METH (4 mg/kg) METH (2 mg/kg) 
Antagonist Group 1 mg/kg Raclopride METH (4 mg/kg) METH (2 mg/kg) 
Figure 7. Schematic Showing Drug Treatments for the Various Groups in 
Experiment 4b 
Data Analysis 
For all experiments, omnibus repeated-measures analyses of variance 
(ANOVAs) were used for statistical analysis of distance traveled data. More 
specifically, pretreatment data for Experiments 1 and 2 were analyzed using 
6 × 6 (Group × 5-min time block) mixed repeated measures ANOVAs, while 
Experiments 3a, 3b, 4a, and 4b were analyzed using 5 × 4 × 6 
(Group × Day × 5-min time block) mixed repeated measures ANOVAs. Test 
day data for Experiments 1 and 2 were analyzed using 6 × 12 
(condition × 10-min time block) repeated measures ANOVAs, whereas 
Experiments 3a, 3b, 4a, and 4b were analyzed using 5 × 12 
(condition × 10-min time block) mixed repeated measures ANOVAs. Post hoc 
analysis of distance traveled data was done using Tukey tests (P < 0.05). The 
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Huynh-Feldt epsilon statistic was used to adjust degrees of freedom (Huynh & 
Feldt, 1976) when the assumption of sphericity was violated, as determined by 
Mauchly’s test of sphericity. Corrected degrees of freedom was represented 
by a superscripted “a” and rounded to the nearest whole number. 
Litter effects were controlled through both experimental design and 
statistical procedures. In most experiments, no more than one subject per 
litter was assigned to a particular group. In cases where this procedure is not 
possible (e.g., analysis of the pretreatment day), a single litter mean was 
calculated from multiple littermates assigned to the same group (Holson & 
Pearce 1992; Zorrilla, 1997). When possible, litter was used as the unit of 
analysis for statistical purposes (Zorrilla, 1997). With this statistical model 
each litter, rather than each rat, was treated as an independent observation 
(i.e., a within analysis using one value/condition/litter). 
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 CHAPTER TEN: 
RESULTS 
Synopsis 
In general, both cocaine and methamphetamine were able to induce 
one-trial and multi-trial behavioral sensitization on PND 17 and PND 21 (see 
Table 1). The only exception was that repeated methamphetamine treatment 
did not cause multi-trial behavioral sensitization when testing occurred on 
PND 21. The dopamine D2-like receptor antagonist raclopride had no effect 
on cocaine- or methamphetamine-induced one-trial behavioral sensitization. 
Furthermore, raclopride did not block the induction of cocaine-induced 
multi-trial sensitization on PND 17 or PND 21. Interestingly, the D2-like 
receptor antagonist was able to prevent the induction of multi-trial 
methamphetamine sensitization when testing occurred on PND 17. Detailed 
coverage of the various experimental results now follows. 
Table 1. Summary of the Test Day Results for the Various Experiments 
Experiment 
Pretreatment 
Age 
Test 
Age Design Agonist Sensitization 
Raclopride’s 
Actions Figure 
1 PD 20 PD 21 One-Trial Cocaine Yes No Effect 9 
2 PD 16 PD 17 One-Trial Methamphetamine Yes No Effect 11 
3a PD 17-PD 20 PD 21 Multi-Trial Cocaine Yes No Effect 13 
3b PD 17-PD 20 PD 21 Multi-Trial Methamphetamine No No Effect 15 
4a PD 13-PD 16 PD 17 Multi-Trial Cocaine Yes No Effect 17 
4b PD 13-PD 16 PD 17 Multi-Trial Methamphetamine Yes Blockade 19 
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Experiment 1: Effects of D2 Receptor Blockade 
on Cocaine-Induced One-Trial Behavioral 
Sensitization 
Pretreatment Day 
When collapsed across the pretreatment day, rats pretreated with 
cocaine alone or cocaine plus raclopride (0.1 or 0.5 mg/kg) had greater 
distance traveled scores than saline controls [group main effect, 
F(3, 18) = 7.99, p < 0.01] (see Figure 8A). The effect was not evident with the 
two higher doses of raclopride (1 or 5 mg/kg) as locomotor activity was 
reduced to the level of the saline controls. The effects of the D2 receptor 
antagonist varied across the session, because rats treated with cocaine plus 
raclopride (0.5, 1, or 5 mg/kg) had smaller distance traveled scores than the 
cocaine-alone group on time blocks 1 and 2 [group × time block interaction, 
F(13,88) = 3.41, p < 0.001; Tukey tests, p < 0.05] (see Figure 8B). 
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Figure 8. Mean Distance Traveled Scores (±SEM) of Rats (n = 8 per group) on 
the Pretreatment Day (PND 20). A. Mean Distance Traveled Scores Collapsed 
Across Time Blocks 1-6. B. Mean Distance Traveled Scores on Time Blocks 
1-6. Rats were Injected with Saline or 30 mg/kg Cocaine Immediately before a 
30-min Placement in activity Chambers (Left Panel). In Addition, Separate 
Group of Rats were Injected with Raclopride (0.1, 0.5, 1, or 5 mg/kg) 15 min 
before Cocaine Treatment (Right Panel). a Significantly Different from the 
Saline Control. b Significantly Different from the Cocaine Alone Group. 
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Test Day 
Cocaine-induced behavioral sensitization was evident in 
nonraclopride-treated rats, because rats pretreated and tested with cocaine 
had greater distance traveled scores than rats treated with only cocaine on the 
test day (i.e., the acute control group; Figure 9) [group main effect, 
F(5,35) = 3.83, p < 0.01, and Tukey tests, p < 0.05]. Interestingly, raclopride 
(0.1, 0.5, 1, or 5 mg/kg) pretreatment did not reduce locomotor activity when 
compared to rats treated with cocaine alone (i.e., raclopride did not block the 
development of behavioral sensitization; see right panel Figure 9). Overall, 
distance traveled scores showed a progressive decline across the testing 
session, with the effect beginning on time block 3 [time main effect, 
F(11,31) = 30.97, P < 0.001] (see Figure 9). 
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Figure 9. Mean Distance Traveled Scores (±SEM) of Rats (n = 8 per Group) on the 
Test Day (PND 21). A. Mean Distance Traveled Scores Collapsed across Time 
Blocks 1-12. B. Mean Distance Traveled Scores on Time Blocks 1-12. Rats were 
Challenged with Cocaine (20 mg/kg) Immediately before Behavioral Testing. On the 
Pretreatment Day, Rats were Injected with Raclopride (0.1, 0.5, 1, or 5 mg/kg) 
15 min before Cocaine Treatment (Right Panel). The Acute Control Group was 
Injected with Saline on the Pretreatment Day and Injected with Cocaine on the Test 
Day (Left Panel). Locomotor Activity was Assessed for 120 min. a Significantly 
different from the Acute Control Group. 
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Experiment 2: Effects of D2 Receptor Blockade on 
Methamphetamine-Induced One-Trial 
Behavioral Sensitization 
Pretreatment Day 
Rats injected with methamphetamine alone or methamphetamine plus 
raclopride (0.1 or 0.5 mg/kg) had greater distance traveled scores than 
saline-treated rats [group main effect, F(5,35) = 7.67, p < 0.001] (see Figure 
10A). These effects varied across the testing session, because rats treated 
with methamphetamine alone had significantly more locomotor activity on time 
blocks 1 and 2 than saline controls [group × time block, F(25,175) = 6.22, 
p < 0.001] (see Figure 10B; left panel). The three higher doses of raclopride 
(0.5, 1, and 5 mg/kg) attenuated locomotor activity on time blocks 1, 2 and 4 
when compared to the methamphetamine alone group (Tukey tests, p < 0.05) 
(see Figure 10B; right panel). 
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Figure 10. Mean Distance Traveled Scores (±SEM) of Rats (n = 8 per Group) on 
the Pretreatment Day (PND 16). A. Mean Distance Traveled Scores Collapsed 
across Time Blocks 1-6. B. Mean Distance Traveled Scores on Time Blocks 1-6. 
Rats were Injected with Saline or 4 mg/kg Methamphetamine Immediately before a 
30-min Placement in Activity Chambers (Left Panel). In addition, Separate Group of 
Rats were Injected with Raclopride (0.1, 0.5, 1, or 5 mg/kg) 15 min before 
Methamphetamine Treatment (Right Panel). a Significantly Different from the Saline 
Control Group. b Significantly Different from the Methamphetamine Alone Group. 
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Test Day 
Overall, rats pretreated and tested with methamphetamine and rats 
pretreated with 1 mg/kg raclopride had greater distance traveled scores than 
the acute control group [group main effect, F(5,35) = 5.54, P < 0.001] (see left 
panel, Figure 11). Rats pretreated and tested with methamphetamine had 
greater distance travel scores than the acute control group on time blocks 
3-11 [group × time block, F(55,385) = 2.68, p < 0.001]. Raclopride 
pretreatment, regardless of dose, did not attenuate locomotor activity on the 
test day (see Figure 11). 
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Figure 11. Mean Distance Traveled Scores (±SEM) of Rats (n = 8 per Group) on 
the Test Day (PND 17). A. Mean distance Traveled Scores Collapsed across Time 
Blocks 1-12. B. Mean Distance Traveled Scores on Time Blocks 1-12. Rats were 
Challenged with Methamphetamine (2 mg/kg) Immediately before Behavioral 
Testing. On the Pretreatment Day, Rats were Injected with Raclopride (0.1, 0.5, 1, 
or 5 mg/kg) 15 min before Methamphetamine Treatment (Right Panel). The Acute 
Control Group was Injected with Saline on the Pretreatment Days and Injected with 
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Methamphetamine on the Test Day (Left Panel). Locomotor was Assessed for 
120 min. a Significantly different from the Acute Control Group 
Experiment 3a: Effects of D2 Receptor Blockade on Cocaine- 
Induced Multi-Trial Behavioral Sensitization During the 
Late Preweanling Period 
Pretreatment Day 
PND 17. Rats injected with cocaine alone or cocaine plus raclopride 
(0.1 mg/kg) had greater distance traveled scores than rats treated with saline 
or moderate to high doses of raclopride (0.5 and 1 mg/kg) [group main effect, 
F(4,28) = 12.17, P < 0.001](see left top panel; Figure 12). Rats treated with 
cocaine alone had greater distance traveled scores on time blocks 1-4 and 6 
when compared to the saline group [group × time block interaction, 
F(20,140) = 3.89, P < 0.001; Tukey tests, P < 0.05]. The effects of the D2 
antagonist varied across the session, because rats treated with cocaine plus 
raclopride (0.5 and 1 mg/kg) had smaller distance traveled scores than the 
cocaine-alone group on time blocks 1 and 2 (Tukey tests, P < 0.05) (see left 
top panel; Figure 12). 
PND 18. Rats injected with cocaine alone or cocaine plus 0.1 mg/kg 
raclopride had greater distance traveled scores than saline-treated rats [group 
main effect, F(4,28) = 9.61, P < 0.001] (see right top panel; Figure 12). More 
specifically, rats treated with cocaine alone had greater locomotor activity on 
time blocks 1 and 2 than saline controls [group × time block interaction, 
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F(20,140) = 5.11, P < 0.001; Tukey tests, P < 0.05]. Rats treated with 0.5 or 
1 mg/kg raclopride had smaller distance traveled scores on time blocks 1 and 
2 than the cocaine alone group (see right top panel; Figure 12). 
PND 19. Rats injected with cocaine alone or cocaine plus a low dose of 
raclopride (0.1 mg/kg) had greater distance traveled scores than 
saline-treated rats [group main effect, F(4,28) = 12.21, P < 0.001] (see left 
bottom panel; Figure 12). Moreover, rats treated with cocaine alone had 
significantly greater locomotor activity on time blocks 1-4 than the saline 
control group. Rats pretreated with raclopride (0.5 or 1 mg/kg) had smaller 
distance traveled scores on time blocks 1-5 than the cocaine alone group 
[group × time block interaction, F(20,140) = 7.17, P < 0.001; Tukey tests, 
P < 0.05] (see left bottom panel; Figure 12). 
PND 20. Rats injected with cocaine alone or cocaine plus 0.1 mg/kg 
raclopride had greater distance traveled scores than saline-treated rats [group 
main effect, F(4,28) = 7.16, P < 0.001] (see right bottom panel; Figure 12). 
More specifically, rats treated with cocaine alone had greater locomotion on 
time blocks 1 and 2 than saline controls, while rats treated with 1 mg/kg 
raclopride had smaller distance traveled scores on time blocks 1 and 2 when 
compared to the cocaine alone group [group × time block interaction, 
F(20,140) = 3.76, P < 0.001; Tukey tests, P < 0.05] (see right bottom panel; 
Figure 12). Starting on time block 3, locomotor activity decreased across time 
[time main effect, F(5,35) = 41.74, P < 0.001]. 
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Figure 12. Mean Distance Traveled Scores (±SEM) of Rats (n = 8 per Group) on 
the Four Pretreatment Days (PD 17, PD 18, PD 19, and PD 20). The Insets Show 
Mean Distance Traveled Collapsed across the Conditioning Session. Rats were 
Injected with Saline or 30 mg/kg Cocaine Immediately before a 30-min Placement 
in Activity Chambers. In Addition, Separate Group of Rats were Injected with 
Raclopride (0.1, 0.5, 1, or 5 mg/kg) 15 min before Cocaine Treatment. a 
Significantly Different from the Saline Control Group. b Significantly different from 
the Cocaine Alone Group. 
Test Day 
PND 21. Rats treated with cocaine alone had greater distance traveled 
scores than the acute control group on the test day [group main effect, 
F(4,28) = 6.37, P < 0.001] (see Figure 13). Raclopride pretreatment, 
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regardless of dose, did not attenuate locomotor activity on the test day (see 
Figure 13). 
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Figure 13. Mean Distance Traveled Scores (±SEM) of Rats (n = 8 per group) on the 
Test Day (PND 21). Rats were Challenged with Cocaine (20 mg/kg) Immediately 
before Behavioral Testing. On the Pretreatment Day, Rats were Injected with 
Raclopride (0.1, 0.5, 1, or 5 mg/kg) 15 min before Cocaine Treatment. The Acute 
Control Group was Injected with Saline on the Pretreatment Days and Injected with 
Cocaine on the Test Day. Locomotor Activity was Assessed for 120 min. The Right 
Panel Shows Mean Distance Traveled Collapsed across the Testing Session. 
a Significantly Different from the Acute Control Group. 
Experiment 3b: Effects of D2 Receptor Blockade on 
Methamphetamine-Induced Multi-Trial Behavioral 
Sensitization During the Late Preweanling Period 
Pretreatment Day 
PND 17. Rats injected with methamphetamine-alone or 
methamphetamine plus raclopride (0.1, 0.5, or 1 mg/kg) had greater distance 
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traveled scores than the saline controls [group main effect, F(4,28) = 7.57, 
P < 0.001](see top left panel; Figure 14). The effects of the D2 antagonist 
varied across the session, because rats treated with methamphetamine alone 
had greater distance traveled scores on time blocks 1-3 than saline controls 
[group × time block interaction, F(20,140) = 3.89, P < 0.001; Tukey tests, 
P < 0.05](see top left panel; Figure 14). Groups receiving methamphetamine 
plus a moderate or high dose of raclopride (0.5 and 1 mg/kg) had smaller 
distance traveled scores than the methamphetamine-alone group on time 
blocks 1 and 2 (Tukey tests, P < 0.05). 
PND 18. Rats injected with methamphetamine-alone or 
methamphetamine plus raclopride (0.1 or 0.5 mg/kg) had greater distance 
traveled scores than saline controls [group main effect, F(4,28) = 21.93, 
P < 0.001] (see top right panel; Figure 14). More specifically, rats treated with 
methamphetamine-alone had greater distance traveled scores on time blocks 
1-6 when compared to saline controls [group × time block interaction, 
F(20, 140) = 11.07, P < 0.001; Tukey tests, P < 0.05]. The three doses of 
raclopride (0.1, 0.5, or 1 mg/kg) caused smaller distance traveled scores on 
time blocks 1, 2, and 3 when compared to the methamphetamine-alone group 
(Tukey tests, P < 0.05). In general, rats treated with raclopride (0.1, 0.5, or 
1 mg/kg) exhibited increased locomotor activity as the session progressed 
[time main effect, F(2,11) = 22.99, P < 0.001; Tukey tests, P < 0.05) (see top 
right panel; Figure 14). 
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PND 19. Rats injected with methamphetamine alone or 
methamphetamine plus raclopride (0.1 or 0.5 mg/kg) had greater distance 
traveled scores than the saline controls [group main effect, F(4,28) = 20.01, 
P < 0.001] (see bottom left panel; Figure 14). More specifically, rats treated 
with methamphetamine alone had greater distance traveled scores than saline 
controls on time blocks 1-6 [group × time block interaction, F(20, 140) = 11.07, 
P < 0.001; Tukey tests, P < 0.05]. The three doses of raclopride (0.1, 0.5, or 
1 mg/kg) caused smaller distance traveled scores on time blocks 1 and 2 
when compared to the methamphetamine-alone group, while 0.5 or 1 mg/kg 
attenuated locomotor activity on time block 3 when compared to the 
methamphetamine-alone group (Tukey tests, P < 0.05) (see bottom left panel; 
Figure 14). 
PND 20. Rats treated with methamphetamine alone or 
methamphetamine plus raclopride (0.1 or 0.5 mg/kg) had greater distance 
traveled scores were compared to saline controls, F(4,28) = 19.99, P < 0.001] 
(see bottom right panel; Figure 14). Rats treated with methamphetamine 
alone had greater distance traveled scores than saline controls on time blocks 
1-6, while raclopride (0.1, 0.5, and 1 mg/kg) attenuated locomotor activity on 
time blocks 1 and 2 when compared to the methamphetamine alone group. 
Raclopride (0.5 and 1 mg/kg) reduced locomotor activity on time block 3 
relative to the methamphetamine-alone group [group × time block interaction, 
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F(20, 140) = 9.04, P < 0.001; Tukey tests, P < 0.05](see bottom right panel; 
Figure 14). 
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Figure 14. Mean Distance Traveled Scores (±SEM) of Rats (n = 8 per Group) on 
the Four Pretreatment Days (PND 17, PND 18, PND 19, and PND 20). The Insets 
Show Mean Distance Traveled Collapsed across the Conditioning Session. Rats 
were Injected with Saline or 4 mg/kg Methamphetamine Immediately before a 
30-min Placement in Activity Chambers. In Addition, Separate Group of Rats were 
Injected with Raclopride (0.1, 0.5, 1, or 5 mg/kg) 15 min before Cocaine Treatment. 
a Significantly Different from the Saline Control Group. b Significantly Different from 
the Methamphetamine Alone Group. 
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Test Day 
PND 21. Rats pretreated with methamphetamine did not differ from the 
acute control group on the test day. Raclopride pretreatment, regardless of 
dose, did not attenuate locomotor activity on the test day (see right panel; 
Figure 15). 
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Figure 15. Mean Distance Traveled Scores (±SEM) of Rats (n = 8 per Group) on 
the Test Day (PND 21). Rats were Challenged with Methamphetamine (2 mg/kg) 
Immediately before Behavioral Testing. On the Pretreatment Days, Rats were 
Injected with Raclopride (0.1, 0.5, 1, or 5 mg/kg) 15 min before Methamphetamine 
Treatment. The Acute Control Group was Injected with Saline on the Pretreatment 
Days and Injected with Methamphetamine on the Test Day. Locomotor Activity was 
Assessed for 120 min. The Right Panel Shows Mean Distance Traveled Collapsed 
across the Testing Session. 
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Experiment 4a: Effects of D2 Receptor Blockade on Cocaine- 
Induced Multi-Trial Behavioral Sensitization During the 
Middle Preweanling Period. 
Pretreatment Day 
PND 13. Rats injected with cocaine alone or cocaine plus 0.5 mg/kg 
raclopride had greater distance traveled scores than saline-treated rats [group 
main effect, F(1,10) = 6.54, P < 0.05] (see top left panel; Figure 16). Overall, 
rats treated with cocaine-alone had greater distance traveled scores on time 
blocks 1-3 and 5-6 than saline controls [group × time block interaction, 
F(20, 140) = 2.62, P < 0.001; Tukey tests, P < 0.05]. Rats treated with 
raclopride (0.1, 0.5, or 1 mg/kg) exhibited less locomotor activity on time 
blocks 1 and 6 than the cocaine alone group (Tukey tests, P < 0.05) (see top 
left panel; Figure 16). 
PND 14. When collapsed across the pretreatment day, rats pretreated 
with cocaine alone or cocaine plus raclopride (0.1 or 0.5 mg/kg) had greater 
distance traveled scores than saline treated rats [group main effect, 
F(2,14) = 12.30, P < 0.001] (see top right panel inset; Figure 16). Rats treated 
with cocaine alone had greater locomotor activity than saline controls on time 
blocks 1, 2, 4, 5, and 6, while raclopride (0.5 or 1 mg/kg) treated rats exhibited 
less locomotor activity than the cocaine-alone group on time blocks 1 and 2 
[group × time block interaction, F(20, 140) = 2.36, P < 0.001; Tukey tests, 
P < 0.05] (see top right panel; Figure 16). 
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PND 15. Overall, rats injected with cocaine alone had greater distance 
traveled scores than rats treated with saline [group main effect, 
F(4,28) = 4.69, P < 0.05] (see bottom left panel inset; Figure 16). This effect 
varied across the testing session, because rats treated with cocaine alone had 
greater distance traveled scores on time blocks 1 and 2 than saline controls; 
the group given cocaine plus 1 mg/kg raclopride exhibited significantly less 
locomotor activity on time blocks 1 and 2 than the cocaine alone group [group 
× time block interaction, F(20, 140) = 3.30, P < 0.001; Tukey tests, P < 0.05] 
(see bottom left panel; Figure 16). 
PND 16. Rats injected with cocaine alone or cocaine plus 0.1 mg/kg 
raclopride had greater distance traveled scores than rats treated with higher 
doses of raclopride (0.5 and 1 mg/kg) [group main effect, F(2,17) = 9.72, 
P < 0.001]. Rats treated with cocaine alone exhibited greater locomotor 
activity on time blocks 1 and 2 than saline controls, while rats treated with 
1 mg/kg raclopride had significantly less locomotion than the cocaine alone 
group on time blocks 1 and 2 [group × time block interaction, 
F(20, 140) = 5.98, P < 0.001; Tukey tests, P < 0.05] (see bottom right panel 
inset; Figure 16). Overall, locomotor activity decreased across the first three 
time blocks for all groups [time main effect, F(2,16) = 12.94, P < 0.001] (see 
bottom right panel; Figure 16). 
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Figure 16. Mean Distance Traveled Scores (±SEM) of Rats (n = 8 per Group) on 
the Four Pretreatment Days (PND 13, PND 14, PND 15, and PND 16). The Insets 
Show Mean Distance Traveled Collapsed across the Conditioning Session. Rats 
were Injected with Saline or 30 mg/kg Cocaine Immediately before a 30-min 
Placement in Activity Chambers. In Addition, Separate Group of Rats were Injected 
with Raclopride (0.1, 0.5, 1, or 5 mg/kg) 15 min before Cocaine Treatment. 
a Significantly Different from the Saline Control Group. b Significantly Different from 
the Cocaine Alone Group. 
Test Day 
PND 17. Rats pretreated and tested with cocaine had greater distance 
traveled scores than the acute control group [group main effect, 
F(4,28) = 8.30, P < 0.001] (see right panel; Figure 17). Moreover, rats 
 63 
challenged with cocaine had greater locomotor activity than the acute control 
group on time blocks 1, 10, 11, and 12 [group × time block interaction, 
F(44, 308) = 5.43, P < 0.001; Tukey tests, P < 0.05]. Raclopride pretreatment, 
regardless of dose, did not attenuate locomotor activity on the test day. 
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Figure 17. Mean Distance Traveled Scores (±SEM) of Rats (n = 8 per Group) on 
the Test Day (PND 17). Rats were Challenged with Cocaine (20 mg/kg) 
Immediately before Behavioral Testing. On the Pretreatment Days, Rats were 
Injected with Raclopride (0.1, 0.5, 1, or 5 mg/kg) 15 min before Cocaine Treatment. 
The Acute Control Group was Injected with Saline on the Pretreatment Days and 
Injected with Cocaine on the Test Day. Locomotor Activity was Assessed for 
120 min. The Right Panel Shows Mean Distance Traveled Collapsed across the 
Testing Session. a Significantly Different from the Acute Control Group. 
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Experiment 4b: Effects of D2 Receptor Blockade on 
Methamphetamine-Induced Multi-Trial Behavioral 
Sensitization During the Middle 
Preweanling Period 
Pretreatment Day 
PND 13. Rats injected with methamphetamine alone or 
methamphetamine plus raclopride (0.1, 0.5, or 1 mg/kg) had greater distance 
traveled scores than saline controls [group main effect, F(4,28) = 9.47, 
P < 0.001](see top left panel inset; Figure 18). Moreover, rats treated with 
cocaine alone exhibited greater locomotor activity on time blocks 1-3 than 
saline controls, while rats pretreated with raclopride (0.1, 0.5, or 1 mg/kg) had 
smaller distance traveled scores on time block 1 than the 
methamphetamine-alone group [group × time block interaction, 
F(20, 140) = 6.60, P < 0.001; Tukey tests, p < 0.001] (see top left panel; 
Figure 18). 
PND 14. Rats injected with methamphetamine-alone or 
methamphetamine plus raclopride (0.1, 0.5, or 1 mg/kg) had greater distance 
traveled scores when compared to the saline controls [group main effect, 
F(4,28) = 19.66, P < 0.001] (see top right panel inset; Figure 18). Moreover, 
rats treated with cocaine alone showed greater locomotion on time blocks 2-5 
than saline controls [group × time block interaction, F(20, 140) = 17.33, 
P < 0.05; Tukey tests, p < 0.001] (see top right panel; Figure 18). Rats 
pretreated with 1 mg/kg raclopride had smaller distance traveled scores on 
time block 1, 2, and 3 (Tukey tests, P < 0.05). 
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PND 15. Rats injected with methamphetamine alone or 
methamphetamine plus raclopride (0.1, 0.5, or 1 mg/kg) had greater distance 
traveled scores than saline controls [group main effect, F(4,28) = 26.13, 
P < 0.001] (see bottom left panel inset; Figure 18). More specifically, rats 
treated with methamphetamine alone had greater locomotor activity on time 
blocks 1 and 2 than saline controls [group × time block interaction, 
F(20, 140) = 41.54, P < 0.001; Tukey tests, P < 0.05]. Rats pretreated with 
raclopride (1 mg/kg) had smaller distance traveled scores on time block 1 and 
2 when compared to the methamphetamine alone group (see bottom left 
panel; Figure 18). 
PND 16. Rats injected with methamphetamine alone or 
methamphetamine plus raclopride (0.1, 0.5, or 1 mg/kg) had greater distance 
traveled scores than the saline controls [group main effect, F(4,28) = 26.82, 
P < 0.001] (see bottom right panel inset; Figure 18). Moreover, rats treated 
with methamphetamine alone exhibited greater locomotion than saline 
controls on time blocks 1 and 2 [group × time block interaction, 
F(20, 140) = 17.33, P < 0.001; Tukey tests, p < 0.05]. Rats pretreated with 
raclopride (1 mg/kg) had smaller distance traveled scores on time blocks 1 
and 2 when compared to the methamphetamine-alone group, but they had 
greater distance traveled scores than the saline group later in the testing 
session (Tukey tests, P < 0.05) (see bottom right panel; Figure 18). 
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Figure 18. Mean Distance Traveled Scores (±SEM) of Rats (n = 8 per Group) on 
the Four Pretreatment Days (PND 13, PND 14, PND 15, and PND 16). The Insets 
Show Mean Distance Traveled Collapsed across the Conditioning Session. Rats 
were Injected with Saline or 4 mg/kg Methamphetamine Immediately before a 
30-min Placement in Activity Chambers. In Addition, Separate Group of Rats were 
Injected with Raclopride (0.1, 0.5, 1, or 5 mg/kg) 15 min before Methamphetamine 
Treatment. a Significantly Different from the Saline Control Group. b Significantly 
Different from the Methamphetamine Alone Group. 
Test Day 
PND 17. Overall, rats pretreated and tested with methamphetamine 
had greater distance traveled scores than the acute control group, while 
pretreatment with (0.5 or 1 mg/kg) raclopride attenuated locomotor activity on 
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the test day [group main effect, F(4,28) = 18.24, P < 0.001] (see right panel, 
Figure 19). Furthermore, rats pretreated and tested with methamphetamine 
exhibited greater locomotion on time blocks 2-12 than the acute control group 
(see left panel Figure 19). Raclopride pretreated rats had smaller locomotor 
activity scores than the methamphetamine alone group (i.e. the sensitized 
group) on time blocks 6-9 [group × time block interaction, F(44, 308) = 5.43, 
P < 0.001; Tukey tests, p < 0.05]. 
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Figure 19. Mean Distance Traveled Scores (±SEM) of Rats (n = 8 per Group) on 
the Test Day (PND 17). Rats were Challenged with Methamphetamine (2 mg/kg) 
Immediately before Behavioral Testing. On the Pretreatment Days, Rats were 
Injected with Raclopride (0.1, 0.5, 1, or 5 mg/kg) 15 min before Methamphetamine 
Treatment. The Acute Control Group was Injected with Saline on the Pretreatment 
Days and Injected with Methamphetamine on the Test Day. Locomotor Activity was 
Assessed for 120 min. Right Panel Show Mean Distance Traveled Collapsed 
Across the Testing Session. a Significantly Different from the Acute Control Group. 
b Significantly Different from the Methamphetamine Alone Group. 
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 CHAPTER ELEVEN: 
DISCUSSION 
Summary of Results and Hypotheses 
The purpose of this thesis was to investigate the importance of D2-like 
receptors for the induction of psychostimulant-induced behavioral sensitization 
during early ontogeny. More specifically, the goals of this thesis were to 
determine the role of D2-like receptors for cocaine- and 
methamphetamine-induced one-trial and multi-trial behavioral sensitization 
during the preweanling period. It was predicted that the D2-like receptor 
antagonist raclopride would prevent the induction of one-trial 
methamphetamine- and cocaine-induced behavioral sensitization at PND 17 
and PND 21, respectively. Furthermore, it was predicted that raclopride would 
block both methamphetamine- and cocaine-induced multi-trial behavioral 
sensitization at PND 17 and PND 21. 
Contrary to predictions, the D2-like receptor antagonist raclopride did 
not attenuate cocaine-induced sensitized responding on PND 21 when a 
one-trial procedure was employed. Furthermore, raclopride did not prevent the 
induction of methamphetamine-induced one-trial behavioral sensitization on 
PND 17. In regards to cocaine-induced multi-trial behavioral sensitization, 
sensitized responding was evident on both PND 17 and PND 21. However, 
the D2-like antagonist raclopride, regardless of dose, was unable to block the 
induction of cocaine-induced behavioral sensitization when assessed on the 
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test day. In contrast to all of the previously mentioned results, higher doses of 
raclopride (0.5 and 1 mg/kg) blocked the induction of 
methamphetamine-induced sensitization on PND 17. Methamphetamine did 
not produce behavioral sensitization during the late preweanling period (i.e. on 
PND 21), nor did raclopride inhibit methamphetamine-induced locomotor 
activity on PND 21. 
Comparing the Present Results to Adult Studies 
Multi-trial Behavioral Sensitization 
Dopamine D2-like receptor antagonists attenuate multi-trial 
methamphetamine-induced behavioral sensitization in adult rats (Kuribara, 
1994). A similar effect was observed in the present study since raclopride (0.5 
and 1 mg/kg) attenuated the multi-trial sensitized responding of preweanling 
rats. The ability of raclopride to block behavioral sensitization is consistent 
with results using other reward-related paradigms, such as sucrose intake and 
conditioned place preference (Mizoguchi, Yamada, Mizuno, Mizuno Nitta, 
Noda, & Nabeshima, 2004; Tyrka, Gayle, & Smith, 1992). The ability of 
raclopride to block the induction of one-trial methamphetamine-induced 
behavioral sensitization in adult rats has not been assessed, so ontogenetic 
comparisons cannot be made. 
According to some earlier studies using adult rodents, dopamine 
D2-like receptor antagonists prevent the induction of multi-trial 
cocaine-induced behavioral sensitization (Mattingly et al., 1996). Based on 
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these studies, it was predicted that raclopride would also attenuate the 
multi-trial cocaine-induced sensitized responding of preweanling rats; 
however, these results were not obtained. Despite using a broad dose range 
of raclopride (0.1-5 mg/kg), the dopamine D2-like receptor antagonist did not 
attenuate the cocaine-induced sensitized responding of preweanling rats. This 
finding implies that dopamine receptors are not involved in the induction of 
multi-trial cocaine-induced behavioral sensitization during the preweanling 
period. Whether these results represent a true ontogenetic difference is 
uncertain, since White et al. (1998) reported that the D2 receptor antagonist 
eticlopride failed to prevent the induction of multi-trial cocaine-induced 
sensitization in adult rats. These authors suggest that earlier studies showing 
D2 receptor involvement in the multi-trial behavioral sensitization of adult rats 
were confounded due to the use of an excessive dose of haloperidol causing 
nonspecific behavioral effects (Mattingly et al., 1996; White et al., 1998). 
One-trial Behavioral Sensitization 
Despite these contradictory findings involving multi-trial behavioral 
sensitization, it does appear that D2 receptor antagonists prevent the 
induction of one-trial behavioral sensitization in adult rats (Fontana et al., 
1993; Weiss et al., 1989). In contrast, dopamine antagonists do not block the 
one-trial behavioral sensitization of preweanling rats (present study; 
Mohd-Yusof et al., 2014). This age-dependent difference may be due to 
environmental conditioning factors. In adult rats and mice, one-trial behavioral 
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sensitization is exclusively context-dependent, while multi-trial sensitization is 
not (Anagnostaras et al., 2002; Battisti et al., 1999; Drew & Glick, 1989). If the 
role of dopamine receptors is to mediate the contextual conditioning aspects 
of behavioral sensitization, then only the one-trial behavioral sensitization of 
adult rats should be sensitive to dopamine receptor blockade. Consistent with 
this suggestion, D1-like and D2-like receptor antagonists only prevent the 
induction of one-trial and not multi-trial cocaine sensitization in adult rats 
(White et al., 1998). Since the one-trial behavioral sensitization of preweanling 
rats is context-independent (Kozanian et al., 2012), then dopamine 
antagonists should not be effective at blocking induction. Consistent with this 
idea, raclopride did not block the cocaine-induced one-trial behavioral 
sensitization of preweanling rats. 
Role of Non-Dopaminergic Receptor Systems 
When considered together, results from adult and preweanling rat 
studies suggest that dopamine receptors either play no role or only a minor 
role in the induction of psychostimulant-induced behavioral sensitization. This 
begs the question as to which neurotransmitter systems are responsible for 
mediating the induction of behavioral sensitization. Cocaine and 
methamphetamine do not exclusively affect dopamine neurons. For example, 
cocaine increases serotonin and norepinephrine levels (Seiden et al., 1993), 
while amphetamine- and methamphetamine-like compounds increase 
norepinephrine levels as well as dopamine (Ritz et al., 1987; Seiden et al., 
 72 
1993). This lack of specificity leaves open the possibility that cocaine and 
methamphetamine may also affect behavioral sensitization by modulating 
serotonergic and/or noradrenergic processes. 
Consistent with this idea, previous studies have shown that serotonin 
5-HT2 antagonists, such as ritanserin, partially block the induction of 
methamphetamine sensitization (Tanaka, Ishigooka, Watanabe, Nagata, & 
Miura, 1998). Cocaine sensitization is also inhibited by the serotonin 5-HT3 
antagonist ondansetron (King, Xiong, & Ellinwood, 1997). The adrenergic 
system may also mediate the induction of behavioral sensitization. In fact, 
Auclair et al. (2004) states that the induction of psychostimulant-induced 
behavioral sensitization is exclusively mediated by 5-HT2A and α-1B adrenergic 
receptors. Thus, the inability of raclopride to block the one-trial behavioral 
sensitization of young rats may indicate that non-dopaminergic systems 
mediate the induction process during the preweanling period. 
Comparing One-Trial and Multi-Trial Behavioral 
Sensitization in Preweanling Rats 
According to Valjent and colleagues (2010), a single exposure protocol 
provides a simple paradigm that can measure the induction of behavioral 
sensitization, while avoiding the problems of tolerance and dependence. 
These authors also suggest that the neural mechanisms mediating one-trial 
and multi-trial methamphetamine-induced behavioral sensitization differ 
(Valjent et al., 2010). In the present study, a dopamine D2-like antagonist was 
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unable to block one-trial methamphetamine-induced behavioral sensitization 
on PND 17. In contrast, repeated treatment with high doses of raclopride (0.5 
and 1 mg/kg) attenuated the induction of multi-trial 
methamphetamine-induced behavioral sensitization on PND 17. 
Several explanations may account for the different pattern of results 
provided by the one- and multi-trial procedures. One possibility is that the 
underlying neural mechanisms mediating one-trial and multi-trial sensitization 
differ. Alternatively, it is possible that repeatedly exposing rats to dopamine 
antagonists may cause nonspecific neural changes (i.e., changes unrelated to 
modifying the acute effects of psychostimulant drugs) that weaken the 
sensitized response. Thus, the impaired sensitized responding that is evident 
when using a multi-trial procedure may be an artifact of repeated antagonist 
administration (Mohd-Yusof et al., 2014). Finally, the multi-trial behavioral 
sensitization of preweanling rats is context-dependent (Wood et al., 1998; 
Zavala et al., 2000), while one-trial behavioral sensitization is 
context-independent (Kozanian et al., 2012). This dichotomy leaves open the 
possibility that D2-like receptor antagonism was interfering with contextual 
conditioning and, thus, only multi-trial behavioral sensitization should be 
disrupted by D2 receptor antagonism. 
Ontogeny of Dopamine Receptors 
Past studies have shown that the dopamine system exhibits 
age-dependent changes across postnatal development. For example, firing 
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rates of neurons in the nigrostriatal pathway increase gradually with age (Pitts 
& Chiodo, 1990). Furthermore, the number of D1-like receptors gradually 
increases until approximately the onset of puberty (PND 40), when dopamine 
receptors are over-expressed. The number of D1-like and D2-like receptors 
then declines (i.e. pruning) to levels that are maintained throughout adulthood 
(Andersen et al., 2000). These changes in synaptic plasticity during 
development, when coupled with early drug exposure, could possibly explain 
the age-dependent differences in pharmacological sensitivity to 
psychostimulants. 
Effects of Raclopride During the Pretreatment Phase 
Data collected on the pretreatment days are also informative. When 
rats were given raclopride (0.1-1 mg/kg) during the pretreatment phase (one- 
or multi-trial), the D2-like antagonist was unable to block the acute locomotor 
activating effects of methamphetamine and cocaine. Importantly, the ability or 
inability of raclopride to block agonist-induced effects on the pretreatment day 
did not determine whether a sensitized response was expressed on the test 
day. For example, raclopride attenuated the acute effects of cocaine during 
the pretreatment phase; however, raclopride did not prevent sensitization from 
being expressed on the test day (see Fig. 16). In contrast, raclopride (0.1 and 
0.5 mg/kg) actually potentiated methamphetamine-induced locomotion by the 
end of the pretreatment phase. Even so, the sensitized response was reduced 
on the test day (see Fig. 18). 
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Other lines of research also suggest that the occurrence or 
non-occurrence of agonist-induced locomotor activity on the pretreatment day 
does not determine whether a sensitized response will be evident on the test 
day. For example, preweanling and adult rats anesthetized during the 
pretreatment phase (i.e., no locomotor activity was possible) exhibited 
behavioral sensitization on the test day (Herbert et al., 2010; Wang & Hsiao, 
2003), while adult mice injected with a D2-like antagonist up to 5 hours after 
methamphetamine pretreatment (i.e., A full locomotor response was evident 
on the pretreatment day) did not exhibit behavioral sensitization (Kuribara, 
1995). Therefore, the induction of behavioral sensitization is independent of 
the overt manifestation of drug-induced locomotor activity during the 
pretreatment phase. 
Summary 
In summary, both cocaine and methamphetamine were able to produce 
behavioral sensitization when a one-trial or a multi-trial procedure was used. 
The dopamine D2-like antagonist raclopride failed to prevent the induction of 
one-trial cocaine- and methamphetamine-induced behavioral sensitization, 
thus D2-like receptor stimulation is unnecessary when a one-trial procedure is 
used. The ability of raclopride to prevent the induction of multi-trial 
methamphetamine-induced sensitization suggests that the neural 
mechanisms underlying behavioral sensitization in young rats differs 
depending on the type of paradigm being employed. Lastly, age-dependent 
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differences in the importance of contextual conditioning may explain why 
D1-like and D2-like receptor antagonists prevent the induction of one-trial 
behavioral sensitization in adult rats, but not rat pups (see also Mohd-Yusof et 
al., 2014). 
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